rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1994-7-28
|
pubmed:abstractText |
To determine whether the ratio of PSA and prostate volume provides additional useful information for the discrimination of benign prostatic hyperplasia from prostatic carcinoma.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0007-1331
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
538-43
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
|
pubmed:year |
1994
|
pubmed:articleTitle |
Prostate-specific antigen corrected for prostate volume improves differentiation of benign prostatic hyperplasia and organ-confined prostatic cancer.
|
pubmed:affiliation |
Department of Urology, University of Münster, Germany.
|
pubmed:publicationType |
Journal Article
|